Both in Pharmaceuticals
Genelux vs Rallybio
Over the past year GNLX returned −74.4% and RLYB returned +241.0%; their daily moves had a correlation of 0.08.
GNLX −74.4% RLYB +241.0%Growth of $1, one year, split-adjusted
| Metric | GNLX | RLYB |
|---|---|---|
| Price | $2.00 | $16.64 |
| Market cap | $90.5M | $88.4M |
| Today | +1.01% | +1.46% |
| 1 month | −17.7% | +0.2% |
| 6 months | −20.6% | +92.8% |
| Year to date | −54.1% | +203.2% |
| 1 year | −68.3% | +270.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.9× |
| Price / sales | 11,311.3× | 136.8× |
| Net cash | $18.7M | $92.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 21.5% |
| Short % of float | 11.4% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).